R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Brain-computer interfaces could redefine precision medicine

BCIs could emerge as a ground-breaking tool for the pharma industry, offering new ways to understand and treat complex conditions.

R&D

From promise to reality: Unlocking the true business potenti...

The genomic medicine space has seen incredible success, but investors are overlooking it.

R&D

The 5th Operationalize Expanded Access Programs banners

Partner Content

Returning... The 5th Operationalize Expanded Access Programs...

Welcome to, or welcome back to, the 5th Operationalize: Expanded Access Programs Summit 2025!

R&D

Growing threat of AMR: UN calls for urgent global action

In response to the rise of AMR, world leaders recently convened at the United Nations General Assembly to forge a landmark commitment, setting ambitious targets and funding initiatives to c

R&D

Webinar recap: Boosting recruitment and retention with SDOH ...

As the pharmaceutical industry continues its shift towards more patient-centric models, the incorporation of social determinants of health (SDOH) data has become increasingly valuable.

R&D